Sclerostin Inhibition for Osteoporosis — A New Approach — NEJM

Retweeted NEJM (@NEJM): Editorial: Sclerostin Inhibition for Osteoporosis — A New Approach. http://t.co/cdbDJGtcVf

via VAT ENGPlus Combo | VATPlus | MotionTrak http://t.co/cdbDJGtcVf